drugset / Trial / NCT00062257
Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as irofulven, use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well irofulven works in treating patients with recurrent or metastatic gastric cancer.
Timeline
- Start
- 2003-06
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | irofulven | Small molecule | — | Intravenous |